Ambu delivered 13.8% organic revenue growth and a 12.0% EBIT margin for FY 2023/24, driven by strong Endoscopy Solutions and improved profitability. Guidance for 2024/25 targets 10–13% organic growth and continued margin expansion.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.